Is Mineralys Therapeutics, Inc. (MLYS) Stock a Biotech Opportunity With Lorundrostat’s Expanding Cardiovascular Potential?
We recently compiled a list of the 8 Best Up and Coming Pharmaceutical Stocks to Buy Now. Mineralys Therapeutics, Inc. (NASDAQ:MLYS) is one of the best up and coming stocks on our list.









